OBJECTIVE: To determine whether maternal methadone dosage affects duration and
degree of neonatal narcotic withdrawal. METHODS: This was a retrospective cohort study of …

Retrospective analysis of 40 infants born to heroin addicted mothers revealed that 85%
developed withdrawal symptoms consisting of central nervous system, gastrointestinal and …

Background Methadone, a full mu-opioid agonist, is the recommended treatment for opioid
dependence during pregnancy. However, prenatal exposure to methadone is associated …

Objective: Compare duration of treatment of neonatal abstinence syndrome between
methadone and morphine. Study design: A prospective, double-masked, randomized trial at …

Selective serotonin reuptake inhibitors (SSRIs) are a new group of antidepressants used in
mild to moderate cases of depression. In studies evaluating the safety of SSRIs during …

Neonates exposed prenatally to opioids will often develop a collection of withdrawal signs
known as neonatal abstinence syndrome (NAS). The incidence of NAS has substantially …

Data on 178 term and 34 preterm infants born to methadone-maintained mothers were
analyzed to assess the effects of neonatal opiate abstinence in infants of varying gestational …

Objective To compare the prevalence and clinical characteristics of neonatal abstinence
syndrome in neonates exposed and not exposed to selective serotonin reuptake inhibitors …

Objectives The objectives of this study were to investigate factors associated with the
development of neonatal abstinence syndrome (NAS) and to assess the implications for …

Aims: To determine the monitoring and treatment of neonatal abstinence syndrome (NAS) in
neonatal intensive care units (NICUs) following opiate or polydrug exposure in utero …